-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Neurocrine Biosciences, Raises Price Target to $185

Benzinga·05/08/2026 18:02:41
Listen to the news
JP Morgan analyst Anupam Rama maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Overweight and raises the price target from $177 to $185.